SCHEMBL6388668

SCHEMBL6388668

CC(C)(C)Oc1ccc(N(c2ccccc2)c2ccccc2C=O)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.35
LMNA P02545 3/20 0.35
GAA P10253 1/20 0.35
ALDH1A1 P00352 6/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
CYP1A2 P05177 1/20 0.35
MEN1 O00255 4/20 0.33
THRB P10828 1/20 0.33
BLM P54132 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
TSHR P16473 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.32
CRHBP P24387 1/20 0.32
ATM Q13315 1/20 0.32
CRHR2 Q13324 1/20 0.32
TLR9 Q9NR96 1/20 0.32
NPSR1 Q6W5P4 2/20 0.31
APP P05067 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6311737 0.84 ALDH1A1 (0.51) KMT2ALMNAALDH1A1CYP2C9CYP2C19
SCHEMBL50149 0.81 KMT2A (0.50) KMT2ALMNAGAAALDH1A1CYP2C9
SCHEMBL6308307 0.80 ALDH1A1 (0.54) KMT2ALMNAALDH1A1CYP2C9CYP2C19
SCHEMBL31298129 0.78 KMT2A (0.50) KMT2ALMNAGAAALDH1A1CYP2C9
SCHEMBL30825194 0.75 KMT2A (0.40) KMT2ALMNAGAAALDH1A1CYP2C9
SCHEMBL3652788 0.75 ALDH1A1 (0.45) KMT2ALMNAGAAALDH1A1CYP2C9
SCHEMBL30022854 0.75 ALDH1A1 (0.45) KMT2ALMNAGAAALDH1A1CYP2C9
SCHEMBL29210809 0.72 SLC6A2 (0.37) KMT2AALDH1A1CYP2C9CYP2C19CYP1A2
SCHEMBL30825175 0.72 LMNA (0.43) KMT2ALMNAGAAALDH1A1MEN1
SCHEMBL31058396 0.71 LMNA (0.46) KMT2ALMNAGAAALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6979746-B2 (1,4-phenylene)bis(methylene) phosphonic acid esters and (1,4-phenylene)bis(methylene) triphenyl phosphonium salt compounds SONY CORPORATION (JP) 2005-12-27 US disclosed
US-20030073863-A1 Bis (aminostyryl) benzene compounds and synthetic intermediates thereof, and process for preparing the compounds and intermediates ICHIMURA MARI (JP) 2003-04-17 US disclosed
US-20030069437-A1 Bis (aminostyryl) benzene compunds and synthetic intermediates thereof, and process for preparing the compounds and intermediates JOLED INC. (JP) 2003-04-10 US disclosed
US-20030060652-A1 Bis (aminostyryl) benzene compounds and synthetic intemediates thereof, and process for preparing the compounds and intermediates ICHIMURA MARI (JP) 2003-03-27 US disclosed
US-6525212-B1 Reacting 4-(N,N-diaryl)aminobenzaldehyde and diphosphonic acid ester or diphosphonium salt SONY CORPORATION (JP) 2003-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030060652-A1 Bis (aminostyryl) benzene compounds and synthetic intemediates thereof, and process for preparing the compounds and intermediates INTS6, IDH3B, IDH3A KMT2A 3540/4885LMNA 310/4885GAA 3105/4885
US-20030073863-A1 Bis (aminostyryl) benzene compounds and synthetic intermediates thereof, and process for preparing the compounds and intermediates DDC, CCNB1, AASDHPPT KMT2A 2487/4885LMNA 465/4885GAA 3454/4885
US-20030069437-A1 Bis (aminostyryl) benzene compunds and synthetic intermediates thereof, and process for preparing the compounds and intermediates DDC, AASDHPPT, DHPS KMT2A 2506/4885LMNA 1070/4885GAA 4109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.